Jaeyong Ahn
executiveMale0.0Global Dominance: 0.00%
Jaeyong Ahn is the CEO of SK bioscience, a key player in the global health preparedness landscape. He leads the company in enhancing the manufacturing and supply processes for the Zaire ebolavirus vaccine, contributing to efforts that aim to improve response capabilities to deadly infectious diseases through strong international collaboration.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jaeyong Ahn is the CEO of SK bioscience and discussed the company's role in improving Ebola vaccine manufacturing.
New $30 Million Push to Make Ebola Vaccines More Affordable and Easier to Store for low- and middle-income countries | NewsDaily Observer – leading Liberian newspaper, est. 1981·
Liberia· 2026-01-27
Liberia· 2026-01-27
